Amarin Corp. Plc(NASDAQ : AMRN)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.38%||168.21||0.7%||$1128.84m|
|LLY||Eli Lilly & Co.||2.73%||318.79||1.1%||$806.60m|
|MRK||Merck & Co., Inc.||0.91%||91.41||0.7%||$800.09m|
|BMY||Bristol-Myers Squibb Co.||0.97%||74.85||1.0%||$652.22m|
|SIGA||SIGA Technologies, Inc.||2.10%||24.83||0.0%||$473.99m|
|GBT||Global Blood Therapeutics, Inc.||0.09%||67.06||5.6%||$333.03m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-1.02%||225.83||8.2%||$273.71m|
|HZNP||Horizon Therapeutics Plc||-2.53%||62.46||5.4%||$214.98m|
|KRTX||Karuna Therapeutics, Inc.||0.76%||265.70||0.0%||$206.59m|
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.